tiprankstipranks
Advertisement
Advertisement
BriaCell Therapeutics Reports Rising Losses and Funding Pressure
PremiumCompany AnnouncementsBriaCell Therapeutics Reports Rising Losses and Funding Pressure
2M ago
BriaCell’s Completed Breast Cancer Combo Study Moves Immunotherapy Story Forward
Premium
Company Announcements
BriaCell’s Completed Breast Cancer Combo Study Moves Immunotherapy Story Forward
2M ago
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR
Premium
Company Announcements
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR
2M ago
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal
PremiumCompany AnnouncementsBriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal
3M ago
BriaPro to purchase BriaCell’s license to develop, commercialize sCD80
Premium
The Fly
BriaPro to purchase BriaCell’s license to develop, commercialize sCD80
3M ago
BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial
Premium
Company Announcements
BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial
3M ago
BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer
PremiumThe FlyBriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer
4M ago
BriaCell Therapeutics Completes $30 Million Public Offering
Premium
Company Announcements
BriaCell Therapeutics Completes $30 Million Public Offering
4M ago
BriaCell Raises $30 Million Through Public Offering of Units and Listed Warrants
Premium
Company Announcements
BriaCell Raises $30 Million Through Public Offering of Units and Listed Warrants
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100